Novel possibilities in pharmacological treatment of childhood leukemia

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorOlumese, Oseikhuemen
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentdeptKenézy Kórház, Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2021-06-16T11:15:02Z
dc.date.available2021-06-16T11:15:02Z
dc.date.created2020-08-13
dc.description.abstractLeukemia is responsible for roughly 30%, a third, of childhood cancers, with acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML) being the most prevalent subtype in children. It usually arises due to either genetic syndromes, environmental and infectious factors or it arises de novo. Symptoms of leukemia include but are not limited to fatigue, fever, excessive sweats, easy bleeding and bruising It is diagnosed by blood tests and biopsies. Treatment for leukemia has improved over the years and it shows that with intense and rigorous therapy remission is indeed possible in some cases. Established treatments like chemotherapy and stem cell transplant have had success in the last half centuryhu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent40hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/311164
dc.language.isoenhu_HU
dc.subjectLeukemiahu_HU
dc.subjectchildhoodhu_HU
dc.subjectcancerhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titleNovel possibilities in pharmacological treatment of childhood leukemiahu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)